Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
Chie Nishioka(Kochi Medical School Hospital), Akihito Yokoyama(Hiroshima University)
Cited by 86
Related Papers
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
|The Lancet Respiratory Medicine|2016|465
Downregulation of miR‐217 correlates with resistance of ph<sup>+</sup> leukemia cells to <scp>ABL</scp> tyrosine kinase inhibitors
|Cancer Science|2013|60
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin
|Lung Cancer|2008|50
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
|International Journal of Cancer|2011|47
Analysis of Aurora B kinase in non-Hodgkin lymphoma
|Laboratory Investigation|2009|39